Patents by Inventor Cesar Mattei

Cesar Mattei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for treating glutamate cytotoxicity with beta-naphthoquinone compounds
    Patent number: 7572774
    Abstract: The present invention relates to the use of beta-naphthoquinone derivatives, and salts thereof, for the prevention and/or the treatment of glutamate cytotoxicity. It further relates to the use of beta-naphthoquinone derivatives, and salts thereof, for preventing and/or treating glutamate induced neurological disorders. Additionally, it concerns the use of beta-naphthoquinone derivatives, and salts thereof, for making drugs exerting an inhibitory effect on the release of glutamate.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: August 11, 2009
    Assignee: Centre National de la Recherche Scientific (C.N.R.S.)
    Inventors: Maurice Israel, Jordi Molgo, Christian Bloy, Cesar Mattei
  • Methods for the prevention and/or the treatment of glutamate cytotoxicity
    Publication number: 20070225236
    Abstract: The present invention relates to the use of beta-naphthoquinone derivatives, and salts thereof, for the prevention and/or the treatment of glutamate cytotoxicity. It further relates to the use of beta-naphthoquinone derivatives, and salts thereof, for preventing and/or treating glutamate induced neurological disorders. Additionally, it concerns the use of beta-naphthoquinone derivatives, and salts thereof, for making drugs exerting an inhibitory effect on the release of glutamate.
    Type: Application
    Filed: May 11, 2007
    Publication date: September 27, 2007
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIC (C.N.R.S.)
    Inventors: Maurice Israel, Jordi Molgo, Christian Bloy, Cesar Mattei
  • Methods for the prevention and/or the treatment of glutamate cytotoxicity
    Publication number: 20070225237
    Abstract: The present invention relates to the use of beta-naphthoquinone derivatives, and salts thereof, for the prevention and /or the treatment of glutamate cytotoxicity. It further relates to the use of beta-naphthoquinone derivatives, and salts thereof, for preventing and/or treating glutamate induced neurological disorders. Additionally, it concerns the use of beta-naphthoquinone derivatives, and salts thereof, for making drugs exerting an inhibitory effect on the release of glutamate.
    Type: Application
    Filed: May 11, 2007
    Publication date: September 27, 2007
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIC (C.N.R.S.)
    Inventors: Maurice Israel, Jordi Molgo, Christian Bloy, Cesar Mattei
  • Methods for the prevention and/or the treatment of glutamate cytotoxicity
    Publication number: 20070225235
    Abstract: The present invention relates to the use of beta-naphthoquinone derivatives, and salts thereof, for the prevention and/or the treatment of glutamate cytotoxicity. It further relates to the use of beta-naphthoquinone derivatives, and salts thereof, for preventing and/or treating glutamate induced neurological disorders. Additionally, it concerns the use of beta-naphthoquinone derivatives, and salts thereof, for making drugs exerting an inhibitory effect on the release of glutamate.
    Type: Application
    Filed: May 11, 2007
    Publication date: September 27, 2007
    Applicant: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIC (C.N.R.S.)
    Inventors: Maurice Israel, Jordi Molgo, Christian Bloy, Cesar Mattei
  • Methods for the prevention and / or the treatment of glutamate cytotoxicity
    Publication number: 20020115617
    Abstract: The present invention relates to the use of beta-naphthoquinone derivatives, and salts thereof, for the prevention and/or the treatment of glutamate cytotoxicity. It further relates to the use of beta-naphthoquinone derivatives, and salts thereof, for preventing and/or treating glutamate induced neurological disorders. Additionally, it concerns the use of beta-naphthoguinone derivatives, and salts thereof, for making drugs exerting an inhibitory effect on the release of glutamate.
    Type: Application
    Filed: January 22, 2002
    Publication date: August 22, 2002
    Inventors: Maurice Israel, Jordi Molgo, Christian Bloy, Cesar Mattei